InvestorsHub Logo
Followers 0
Posts 878
Boards Moderated 0
Alias Born 10/22/2015

Re: Frayed Knot post# 3321

Saturday, 10/22/2016 11:47:01 AM

Saturday, October 22, 2016 11:47:01 AM

Post# of 6772
I followed it in 2014. It ran up to $18.25 because they HAD entered the Marijuana Space! The change in filings was delayed.

ALAN BROCHSTEIN'S
420 Investor

I have posted some info on UCAN in the forum and have posted a blog here as well (interview with CEO). The company just announced a deal with a Canadian company. I have previously spoken with a senior person at WeedMD who I met in Vancouver at the GreenRush Financial conference and found the company to be interesting.

United Cannabis & WeedMD Enter Exclusive Bi-Lateral Partnership
New Canadian Medical Marijuana Company Will Benefit From the Services and Expertise From Colorado-Based Cannabis Consulting Company


DENVER, CO and TORONTO, ON, Jun 05, 2014 (Marketwired via COMTEX) -- United Cannabis Corporation (otcqb:CNAB) (United Cannabis"), a Colorado-based bio cannabinoid technology, management and consulting company, and WeedMD Rx Inc. ("WeedMD"), an emerging medical marijuana producer in Alymer, Ontario, have established an exclusive strategic partnership to assist in all aspects of the growing, production and distribution of medical marijuana in Canada. The deal also positions United Cannabis and WeedMD as 50/50 partners to invest in future potential projects in Canada and in the US.

As the Canadian medical marijuana industry grows through the introduction of Health Canada's newly launched Marihuana for Medical Purposes Regulations - MMPR program, United Cannabis and WeedMD plan to bring the latest bio cannabinoid technology to Canadian patients. This partnership has the potential to revolutionize the medical cannabis industry in Canada with its focus on scientific research, product development and implementation of its proprietary cannabinoid therapy program.

"WeedMD is thrilled to be bringing United Cannabis Corporation's incredible experience and expertise in bio cannabinoid therapy to Canada through this important partnership," says Michael Kraft, Chairman of WeedMD. "Cannabis is one of the safest therapeutically active substances known when used under medical supervision. WeedMD is committed to providing Canadian patients with the most in-depth and current information. United Cannabis is one of the strongest leaders in the US and we are honoured to be part of their team."

The United Cannabis team brings 30 years of combined experience working in the medical marijuana industry. With access to hundreds of strains (including more than 15 unique CBD-dominant varieties), and the A.C.T Now program (Advanced Cannabinoid Therapy) combined with data and patient stories, United Cannabis will significantly improve WeedMD's market position and offering in the rapidly growing Canadian market.

United Cannabis' CEO Paul Enright said, "This agreement is at our core- to partner with other like-minded individuals and companies in the cannabis industry to replicate and proliferate the United Cannabis business model. We are delighted to be working with WeedMD as our strategic partner in Canada and look forward to bringing our experience and years of expertise to the Canadian market and being a part of WeedMD's success."

About United Cannabis Corporation United Cannabis has a foundation in the cannabis industries. With our consulting services, management and oversight we are capable of assisting any Cannabis oriented company on any scale. United Cannabis is now partnering domestically and internationally with local businessmen, entrepreneurs, and scientists for the purpose of promoting Best Practices in: Planning, Procedures, Governance and Patient Care. The company's consulting services will also provide guidance on design and construction for Grow Operations and the cultivation of medical grade cannabis-based products worldwide. With access to a catalogue of award winning genetics and coupled with our leadership and experience, we are positioned to take any cannabis business through all of the steps for success. For further information, please visit www.unitedcannabis.us

About WeedMD Rx Inc. WeedMD is a medical marijuana company, which has secured pre-license approval from Health Canada to produce and distribute 2,500 kg of medical marijuana. WeedMD's operations are based in Aylmer, Ontario in a 25,000 sq. ft. converted tobacco plant which is being retrofitted for medical marijuana and has the potential to expand to 160,000 sq. ft. WeedMD has a strategic partnership with United Cannabis, a leading bio-cannabinoid technology, management and consulting company based in Colorado. WeedMD's team includes industry and health professionals with significant experience and expertise in seniors' healthcare, many of whose patients use or plan to use medical marijuana. WeedMD has hired leading growers, quality assurance and R&D professionals to manage plant physiology, phyto-sanitary issues and active ingredient concentrations. www.weedmd.com
Posted on June 5, 2014, 9:57 a.m.



http://investorplace.com/2014/07/trade-of-the-day-united-cannibas-corp-cnab-marijuana-stocks/#.WAuJStyKabL


Trade of the Day: United Cannibas Corp. (CNAB)
A blazin' marijuana stock chart
By Profit Scanner | Jul 3, 2014, 9:52 am EDT
RSS Logo Profit Scanner
Recent Posts:
3 Energy Stocks Boosted by the OPEC Surprise
3 Energy Stocks Searching for a Bottom
Trade of the Day: Barclays PLC (ADR) (NYSE:BCS)
View All Posts

As many in the United States look forward to a long weekend to commemorate the Fourth of July holiday with hot dogs and fireworks, Profit Scanner powered by Recognia uncovered a hit from the group of marijuana stocks that looks to be igniting.

Colorado-based United Cannibas Corp. (CNAB) launched in 2007 and acts as a consultant and supplier for medical marijuana treatments. Like many marijuana stocks, shares of CNAB were worth just a few cents when it went public in late 2013, but it has skyrocketed more than 1000% to hit the $10 range at its high.

CNAB has since settled down, but spiked big-time at the end of June from less than $1 to about $3.50. Traders are wondering if marijuana stocks can keep getting higher, and, according to CNAB’s chart, the answer is yes.

At the July 2 close, CNAB’s chart indicated a bullish Head and Shoulders Bottom pattern emerged, which could take the stock from current levels of $3.40 to a high-side target of $5.40 to $5.90.

marijuana stocksThe Head and Shoulders Bottom pattern is expected to play out in just 39 trading days. So, if the pattern is valid, the target should be achieved by approximately the end of August for at least a 58% gain at the low-end

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.